March National Provider Data Summary

Updated: Aug 28, 2019

March National Provider Data Summary

The following 2 Trusts did not submit any RTT pathway data:

  • Mid Essex Hospital Services NHS Trust (RQ8)

  • Royal Free London NHS Foundation Trust (RAL)

RTT Performance

As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to March 2018. 



Waiting List Size

As the below graph demonstrates, from March 2018 to March 2019 the total waiting list size increased from 3,843,182 to 4,232,436, an increase of 389,254 (10.13%).


Below is a table showing each reporting Trusts variance in waiting list size from March 2018 to March 2019, sorted by percentage variance (please click to view the whole table).


52 Week Waiters

The below heatmap shows how the number of 52-week waiters has changed nationally, with areas such as the East Midlands and South managing to reduce their number of 52-week waiters.


Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2018 to March 2019, sorted by percentage variance (please click to view the whole table).


Changes to the Individual Specialties

In regard to the waiting list size of the individual specialties:


  • Plastic Surgery saw a percentage decrease in waiting list size going from 52,692 to 52,660  in waiting list size going from 1.21% and Plastic Surgery seeing a percentage decrease of 0.06%. 

  • General Surgery also saw a high decrease in the waiting list size going from 317,920 to 314,079, a decrease of -3,841 pathways. 

  • Gynaecology and ENT saw a percentage increase of the waiting list size with Gynaecology going from 263,720 to 274,298, a percentage increase of 4.01% and ENT going from 293,344 to 304,350, a percentage increase of 3.75%. 

  • Other, as a single specialty saw the largest increase of pathways, going from 864,153 to 893,148, an increase of 28,995 pathways (3.56%).



Summary

  • At the end of March 2019, 86.7% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard, and a waiting list size of 4,232,436.

  • The number of RTT patients waiting to start treatment at the end of March 2019 increased by 5.9% compared to the end of March 2018.

  • For patients waiting to start treatment at the end of March 2019, the median waiting time was 6.9 weeks. The 92nd percentile waiting time was 22.3 weeks.​

  • During March 2019, 305,356 RTT patients started admitted treatment and 1,095,002 started non-admitted treatment (completed pathways).

Comments

The Planning Guidance for reducing the size of the waiting list was not achieved leaving us to wonder what will be the baseline for the 2019/2020 guidance which again requests a reduction in the size of the waiting list . Will trusts have to achieve the 18/19 guidance alongside the 19/20 guidance or will the starting point be adjusted?